Association of apolipoprotein E epsilon 4 allele with sporadic late onset alzheimer's disease: A meta-analysis

Neurosciences

Volumn 17, Issue 4, 2012, Pages 321-326

  Sadigh Eteghad, Saeed ^a   Talebi, Mahnaz ^a   Farhoudi, Mehdi ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84922685825     PISSN: 13196138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Blennow K, de Leon MJ, Zetterberg H. Alzheimer's disease. Lancet 2006; 368: 387-403.Review.
2. Aslan D, Ercan F, Aybek H, Sahiner T. APOE Epsilon4 Allele Frequency in Patients with Dementia in Different Ethnic and Geographic Groups. Turk J Biochem 2010; 35: 163-171.
3. Takei N, Miyashita A, Tsukie T, Arai H, Asada T, Imagawa M, et al. Genetic association study on in and around the APOE in late-onset Alzheimer disease in Japanese. Genomics 2009; 93: 441-448.
4. Hall K, Murrell J, Ogunniyi A, Deeg M, Baiyewu O, Gao S, et al. Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba. Neurology 2006; 66: 223-227.
5. Raygani AV, Zahrai M, Raygani AV, Doosti M, Javadi E, Rezaei M, et al. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran. Neurosci Lett 2005; 375: 1-6.
6. Hoshino T, Kamino K, Matsumoto M. Gene dose effect of the APOE-ε4 allele on plasma HDL cholesterol level in patients with Alzheimer's disease. Neurobiol Aging 2002; 23: 41-45.
7. Lovati C, Galimberti D, Albani D, Bertora P, Venturelli E, Cislaghi G, et al. APOE ε2 and ε4 influence the susceptibility for Alzheimer's disease but not other dementias. Int J Mol Epidemiol Genet 2010; 1: 193-200.
8. Rassas AA, Mrabet Khiari H, Hadj Fredj S, Sahnoun S, Batti H, Zakraoui NO, et al. High APOE epsilon 4 allele frequencies associated with Alzheimer disease in a Tunisian population. Neurol Sci 2012; 33: 33-37.
9. RevMan. Review Manager (Computer program). RevMan. Version 5.0 for Windows. The Nordic Cochrane Centre (Denmark): The Cochrane Collaboration; 2008.
10. Harris RJ, Bradburn MJ, Deeks JJ, Harbord RM, Altman DG, Sterne JAC. metan: fixed- and random-effects meta-analysis. Stata Journal 2008; 8: 3-28.
11. Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.0.0. The Cochrane Collaboration; 2008. Available from: www.cochrane-handbook.org
12. Sterne JAD, Harbord RM. Funnel plots in meta-analysis. Stata Journal 2004; 4: 127-141.
13. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services task force of Alzheimer's disease. Neurology 1984; 34: 939-944.
14. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993; 11: 575-580.
15. Ueki A, Kawano M, Namba Y, Kawakami M, Ikeda K. A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease. Neurosci Lett 1993; 163: 166-168.
16. Betard C, Robitaille Y, Gee M, Tiberghien D, Larrivee D, Roy P, et al. Apo E allele frequencies in Alzheimer's disease, Lewy body dementia, Alzheimer's disease with cerebrovascular disease and vascular dementia. Neuroreport 1994; 5: 1893-1896.
17. Chartier-Harlin MC, Parfitt M, Legrain S, Perez-Tur J, Brousseau T, Evans A, et al. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet 1994; 3: 569-574.
18. Frisoni GB, Calabresi L, Geroldi C, Bianchetti A, D'Acquarica AL, Govoni S, et al. Apolipoprotein E epsilon 4 allele in Alzheimer's disease and vascular dementia. Dementia 1994; 5: 240-242.
19. Benjamin R, Leake A, Ince PG, Perry RH, McKeith IG, Edwardson JA, et al. Effects of apolipoprotein E genotype on cortical neuropathology in senile dementia of the Lewy body and Alzheimer's disease. Neurodegeneration 1995; 4: 443-448.
20. Benjamin R, Leake A, McArthur FK, Candy JM, Ince PG, Edwardson JA, et al. Apolipoprotein E genotype and Alzheimer's disease in an elderly Norwegian cohort. Neurodegeneration 1996; 5: 43-47.
21. Fallin D, Gauntlett AC, Scibelli P, Cai X, Duara R, Gold M, et al. No association between the very low density lipoprotein receptor gene and late-onset Alzheimer's disease nor interaction with the apolipoprotein E gene in population-based and clinic samples. Genet Epidemiol 1997; 14: 299-305.
22. Wang JC, Kwon JM, Shah P, Morris JC, Goate A. Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease. Neurology 2000; 55: 1644-1649.
23. Jacquier M, Arango D, Villareal E, Torres O, Serrano ML, Cruts M, et al. ApoE e4 and Alzheimer disease: positive association in a Colombian clinical series and review of the Latin-American studies. Arq Neuropsiquiatr 2001; 59: 11-17.
24. Molero AE, Pino-Ramirez G, Maestre GE. Modulation by age and gender of risk for Alzheimer's disease and vascular dementia associated with the apolipoprotein E-epsilon4 allele in Latin Americans: findings from the Maracaibo Aging Study. Neurosci Lett 2001; 307: 5-8.
25. Souza DR, de Godoy MR, Hotta J, Tajara EH, Brandão AC, Pinheiro Júnior S, et al. Association of apolipoprotein E polymorphism in late-onset Alzheimer's disease and vascular dementia in Brazilians. Braz J Med Biol Res 2003; 36: 919-923.
26. Gdovinova Z, Habalova V, Novosadova Z. Polymorphism of apolipoproteine E in relation with Alzheimer and vascular dementia. Cell Mol Neurobiol 2006; 26: 1219-1224.
27. Raygani AV, Rahimi Z, Kharazi H, Tavilani H, Pourmotabbed T. Association between apolipoprotein E polymorphism and serum lipid and apolipoprotein levels with Alzheimer's disease. Neurosci Lett 2006; 408: 68-72.
28. Bahia VS, Kok F, Marie SN, Shinjo SO, Caramelli P, Nitrini R. Polymorphisms of APOE and LRP genes in Brazilian individuals with Alzheimer disease. Alzheimer Dis Assoc Disord 2008; 22: 61-65.
29. Smach MA, Charfeddine B, Lammouchi T, Othman LB, Letaief A, Nafati S, et al. Analysis of association between bleomycin hydrolase and apolipoprotein E polymorphism in Alzheimer's disease. Neurol Sci 2010; 31: 687-691.
30. Gozalpour E, Kamali K, Mohammd K, Khorram-Khorshid HR, Ohadi M, Karimloo M, et al. Association between Alzheimer's Disease and Apolipoprotein E Polymorphisms. Iranian J Publ Health 2010; 39: 1-6.
31. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003; 33: 177-182.
32. Sagoo GS, Little J, Higgins JPT. Systematic reviews of genetic association studies. PLoS Med 2009; 63: e28. doi:10.1371/ journal.pmed.1000028
33. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 2007; 39: 17-23.
34. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993; 342: 697-699.
35. Ward A, Crean S, Mercaldi CJ, Collins JM, Boyd D, Cook MN, et al. Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer's disease: a systematic review and meta-analysis. Neuroepidemiology 2012; 38: 1-17.
36. Sjogren M, Mielke M, Gustafson D, Zandi P, Skoog I. Cholesterol and Alzheimer's disease--is there a relation? Mech Ageing Dev 2006; 127: 138-147.